Work

Amplification-Free On-Site Rapid Detection of Hendra Virus Using CRISPR and Field-Effect Transistors

Year: 2026
Type: article
Abstract: Hendra virus (HeV) is a zoonotic pathogen that can cause severe disease in humans. Because early symptoms are nonspecific and no licensed human vaccine or specific antiviral treatment is available, rapid testing may support timely clinical management. We developed an amplification-free CRISPR-field-effect transistor (CRISPR-FET) assay for HeV RNA. This study reports a novel amplification-free nucleic acid detection platform (CRISPR-FET) that integrates the specific collateral cleavage activity of CRISPR/Cas13a with the sensitive transduction capability of FETs. The CRISPR-FET platform achieves sensitive detection of Hendra virus nucleic acids with a limit of detection as low as 101 copies/μL (Ct value 33.0), eliminating the need for target nucleic acid preamplification and significantly streamlining the diagnostic process. To validate the specificity and reliability of this approach, we conducted cross-reactivity tests using eight RNA viruses with clinically similar symptoms and evaluated detection performance with 26 simulated clinical samples. However, the current study was performed using simulated rather than authentic clinical specimens, and the assay provides qualitative rather than quantitative results. Further validation with a larger number of clinical samples are required before clinical application.
Source: Molecules
Language: English
Open Access status: gold
Estimated APC paid: $3,258
OpenAlex ID: W7225876376
FWCI:
Cites: 39
Cited by:
Related to: 10